Translational funding
Follow-on funding
Our funding events in Follow-on funding are shown below.
-
BBSRC - Follow-on funding
This funding is for ‘proof of concept’ at the very early stage of turning research outputs into a commercial proposition.
It funds work to convert an idea into a robust business plan where a route to commercialisation is clear, for example a spin-out (seed or venture finance) or licensing opportunity.
-
BBSRC - Follow-on funding pathfinder scheme
The BBSRC new pathfinder scheme enables potential follow-on funding applicants to secure small amounts of funding to carry out preliminary commercial activities.
-
BBSRC Super Follow on Funding
A small number of larger strategic awards are available called Super follow-on funding grants, from the BBSRC. This is a pilot scheme and there will be 2 calls for applications to Super follow on funds in 2012.
-
EPSRC - Follow-on-fund
The Follow-on Fund helps researchers to bridge the funding gap between traditional research grants and commercial funding by supporting the very early stage of turning research outputs into a commercial proposition. After completing the follow-on work, the prospective business idea should be in a much stronger position to secure further support from venture capital or seed funds.
-
MRC - Developmental Pathway Funding Scheme/Developmental Clinical Studies
Therapeutics, Devices and Diagnostics Development
The Developmental Pathway Funding Scheme/Developmental Clinical Studies scheme (DPFS/DCS) supports the translation of fundamental discoveries toward benefits to human health. It funds the pre-clinical development and early clinical testing of novel therapeutics, devices and diagnostics, including “repurposing” of existing therapies.The DPFS/DCS scheme combines the previous individual translational funding schemes, permitting a more flexible and integrated approach to the development of new interventions and diagnostics. This scheme forms part of the MRC’s Translational Research Strategy.
-
NIHR - i4i Invention for Innovation
Supporting either early- or late-stage product development, i4i is positioned to transform the translation of healthcare technologies for increased patient benefits